KalVista Pharmaceuticals, Inc.
Hedge Funds Holdings
Last updated:
KalVista Pharmaceuticals, Inc.‘s stocks are currently a part of 83 hedge funds’ portfolios, which represents 99.38% of the total amount of its stocks outstanding. This makes up a total of 24.32M shares of KalVista Pharmaceuticals, Inc.. Compared to the previous quarter, the number grew by 2.29% or 544.11K shares more. As for the holding position changes, 37.35% (31) of current hedge fund investors increased the number of shares held, 32.53% (27) of current holders sold a part of the shares held, and 24.1% (20) closed the holdings completely. 8 hedge funds are new holders of KalVista Pharmaceuticals, Inc. stock in Q1 2022, it is 9.64% of total holders.
Hedge funds holding KalVista Pharmaceuticals (Q2 2017 – Q1 2022)
| Q2 2017 | 18 |
|---|---|
| Q3 2017 | 16 |
| Q4 2017 | 23 |
| Q1 2018 | 24 |
| Q2 2018 | 26 |
| Q3 2018 | 48 |
| Q4 2018 | 57 |
| Q1 2019 | 68 |
| Q2 2019 | 73 |
| Q3 2019 | 76 |
| Q4 2019 | 73 |
| Q1 2020 | 68 |
| Q2 2020 | 72 |
| Q3 2020 | 61 |
| Q4 2020 | 82 |
| Q1 2021 | 116 |
| Q2 2021 | 110 |
| Q3 2021 | 103 |
| Q4 2021 | 95 |
| Q1 2022 | 83 |
Hedge funds changes in KalVista Pharmaceuticals positions (Q2 2017 – Q1 2022)
| Q2 2017 | 2 | 4 | 3 | 2 | 7 |
|---|---|---|---|---|---|
| Q3 2017 | 2 | 5 | 3 | 4 | 2 |
| Q4 2017 | 12 | 3 | 2 | 5 | 1 |
| Q1 2018 | 5 | 4 | 7 | 4 | 4 |
| Q2 2018 | 4 | 6 | 5 | 2 | 9 |
| Q3 2018 | 25 | 9 | 9 | 3 | 2 |
| Q4 2018 | 17 | 18 | 9 | 8 | 5 |
| Q1 2019 | 17 | 20 | 16 | 6 | 9 |
| Q2 2019 | 22 | 20 | 18 | 17 | -4 |
| Q3 2019 | 15 | 21 | 19 | 12 | 9 |
| Q4 2019 | 19 | 28 | 14 | 17 | -5 |
| Q1 2020 | 10 | 25 | 21 | 13 | -1 |
| Q2 2020 | 14 | 24 | 18 | 10 | 6 |
| Q3 2020 | 3 | 23 | 20 | 14 | 1 |
| Q4 2020 | 25 | 21 | 24 | 4 | 8 |
| Q1 2021 | 53 | 43 | 17 | 18 | -15 |
| Q2 2021 | 18 | 40 | 38 | 25 | -11 |
| Q3 2021 | 15 | 34 | 32 | 21 | 1 |
| Q4 2021 | 16 | 32 | 28 | 23 | -4 |
| Q1 2022 | 8 | 31 | 27 | 20 | -3 |
Hedge funds changes in KalVista Pharmaceuticals stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 0 | 0 |
|---|---|---|
| Q3 2017 | 0 | 0 |
| Q4 2017 | 0 | 0 |
| Q1 2018 | 0 | 0 |
| Q2 2018 | 0 | 0 |
| Q3 2018 | 0 | 0 |
| Q4 2018 | 0 | 0 |
| Q1 2019 | 0 | 0 |
| Q2 2019 | 0 | 0 |
| Q3 2019 | 0 | 0 |
| Q4 2019 | 0 | 0 |
| Q1 2020 | 0 | 0 |
| Q2 2020 | 0 | 0 |
| Q3 2020 | 0 | 0 |
| Q4 2020 | 5,600,000 | 6,684,000 |
| Q1 2021 | 3,588,000 | 8,292,000 |
| Q2 2021 | 2,447,000 | 5,036,000 |
| Q3 2021 | 533,000 | 3,539,000 |
| Q4 2021 | 164,000 | 138,000 |
| Q1 2022 | 1,662,000 | 0 |